Literature DB >> 31141388

A systemic treatment confronts a systemic disease.

Lawrence E Hightower1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31141388      PMCID： PMC6692756          DOI： 10.1152/ajpregu.00142.2019

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN： 0363-6119            Impact factor:   3.619


× No keyword cloud information.
  12 in total

1.  Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Authors:  E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Current treatment of severe sepsis.

Authors:  Ismail Cinel; R Phillip Dellinger
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

3.  Why have clinical trials in sepsis failed?

Authors:  John C Marshall
Journal:  Trends Mol Med       Date:  2014-02-24       Impact factor: 11.951

Review 4.  Hyperbaric oxygen: its mechanisms and efficacy.

Authors:  Stephen R Thom
Journal:  Plast Reconstr Surg       Date:  2011-01       Impact factor: 4.730

Review 5.  Therapeutic Targets in Sepsis: Past, Present, and Future.

Authors:  Eric J Seeley; Gordon R Bernard
Journal:  Clin Chest Med       Date:  2016-03-18       Impact factor: 2.878

Review 6.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Intensive Care Med       Date:  2003-03-28       Impact factor: 17.440

7.  Hyperbaric oxygen induces a cytoprotective and angiogenic response in human microvascular endothelial cells.

Authors:  Cassandra A Godman; Kousanee P Chheda; Lawrence E Hightower; George Perdrizet; Dong-Guk Shin; Charles Giardina
Journal:  Cell Stress Chaperones       Date:  2009-12-01       Impact factor: 3.667

8.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

Review 9.  Treatment of severe sepsis: where next? Current and future treatment approaches after the introduction of drotrecogin alfa.

Authors:  Todd W Rice
Journal:  Vasc Health Risk Manag       Date:  2006

Review 10.  Epidemiology of severe sepsis.

Authors:  Florian B Mayr; Sachin Yende; Derek C Angus
Journal:  Virulence       Date:  2013-12-11       Impact factor: 5.882
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.